5-Year Outcomes With a Novel Coronary Sirolimus-Eluting Bioresorbable Scaffold
JACC: Cardiovascular Interventions · 2025-09 · 18 (17) · 2107-2115
DOI: 10.1016/j.jcin.2025.06.036 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift JACC: Cardiovascular Interventions, 2025-09. Verfasst von Kai Xu und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, General Hospital of Northern Theater Command, Shenyang, China. Hauptthemen laut MEDLINE: Absorbable Implants, Coronary Artery Disease, Percutaneous Coronary Intervention, Cardiovascular Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 20 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, General Hospital of Northern Theater Command, Shenyang, China.
- Department of Cardiology, Sir Run Run Shaw Hospital, Hangzhou, China.
- Department of Cardiology, Fu Wai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Beijing, China.
- Department of Cardiology, Xijing Hospital, the Fourth Military Medical University, Xi'an, China.
- Department of Cardiology, the First Affiliated Hospital of Guangxi Medical University, Nanning, China.
- Department of Cardiology, Nanfang Hospital, Guangzhou, China.
Zitieren
APA
Xu, K., Fu, G., Wang, X., Song, L., Tao, L., Li, L., Hou, Y., Su, X., Fang, Q., Chen, L., Liu, H., Wang, B., Yuan, Z., Gao, C., Zhou, S., Guan, C., Li, Y., Han, Y., Stone, G. W., & NeoVas Randomized Controlled Trial Investigators (2025). 5-Year Outcomes With a Novel Coronary Sirolimus-Eluting Bioresorbable Scaffold. JACC: Cardiovascular Interventions, 18(17), 2107-2115. https://doi.org/10.1016/j.jcin.2025.06.036
Vancouver
Xu K, Fu G, Wang X, Song L, Tao L, Li L, et al. 5-Year Outcomes With a Novel Coronary Sirolimus-Eluting Bioresorbable Scaffold. JACC: Cardiovascular Interventions. 2025;18(17):2107-2115. doi:10.1016/j.jcin.2025.06.036
BibTeX
@article{Xu2025,
author = {Xu, Kai and Fu, Guosheng and Wang, Xiaozeng and Song, Lei and Tao, Ling and Li, Lang and Hou, Yuqing and Su, Xi and Fang, Quan and Chen, Lianglong and Liu, Huiliang and Wang, Bin and Yuan, Zuyi and Gao, Chuanyu and Zhou, Shenghua and Guan, Changdong and Li, Yi and Han, Yaling and Stone, Gregg W and NeoVas Randomized Controlled Trial Investigators, NeoVas Randomized Controlled Trial Investigators},
title = {5-Year Outcomes With a Novel Coronary Sirolimus-Eluting Bioresorbable Scaffold},
journal = {JACC: Cardiovascular Interventions},
year = {2025},
volume = {18},
number = {17},
pages = {2107--2115},
doi = {10.1016/j.jcin.2025.06.036}
}
EUVIMED